Today’s New York Times has an opinon piece about depression pills. Regardless of whether or not people perceive they benefit from SSRIs–or any drug–everyone can agree that all should receive informed consent about real risks vs possible benefits BEFORE prescribing.

Read the full article at https://www.nytimes.com/2025/05/17/opinion/rfk-health-antidepressants.html.